Despite the increasing prevalence of metabolic disorders, the potential effects of metabolic factors on hepatocellular carcinoma (HCC) development in individuals with chronic liver diseases (CLDs) are not well understood. For a metabolic factor to be identified as a risk factor for HCC in patients with CLDs, such as hepatitis B virus (HBV) and hepatitis C virus (HCV) infection, there should be a strong synergistic interaction between the carcinogenic mechanisms of the metabolic factor and the CLD itself. This review aims to comprehensively summarize the published data on the relationship between metabolic factors such as diabetes mellitus (DM), obesity, and blood lipids and the risk of HCC in patients with CLDs. DM consistently increases the risk of HCC in patients with CLD. When associated with DM, the risk of HCC seems to be highest in HCV and non-alcoholic fatty liver disease (NAFLD), followed by alcoholic liver disease (ALD) and HBV. Obesity may increase the risk of HCC. Among CLDs, the evidence is relatively consistent and clear for ALD, while clear evidence is limited in other CLDs including HBV, HCV, and NAFLD. Total cholesterol, potentially low-density lipoprotein cholesterol and triglyceride, seems to have strong inverse associations with HCC in individuals with CLDs. Despite evidence from observational studies, statins had no effect in preventing HCC in randomized controlled trials. Whether statins have a preventive effect against HCC is unclear. A better understanding and management of metabolic factors may be beneficial to reduce the risk of HCC in patients with CLDs.
Citations
Citations to this article as recorded by
Prevention of liver cancer in the era of next-generation antivirals and obesity epidemic Hiroyuki Suzuki, Naoto Fujiwara, Amit G. Singal, Thomas F. Baumert, Raymond T. Chung, Takumi Kawaguchi, Yujin Hoshida Hepatology.2026; 84(1): 292. CrossRef
Components of cardiometabolic risk factors predict liver-related events in patients cured of hepatitis C Virus Wei-Fan Hsu, Hsueh-Chou Lai, Hung-Wei Wang, Sheng-Hung Chen, Wen-Pang Su, Hung-Yao Chen, Guan-Tarn Huang, Cheng-Yuan Peng Journal of Microbiology, Immunology and Infection.2026; 59(2): 181. CrossRef
Decoding the functional network of circular RNAs encoding proteins in hepatocellular carcinoma: from carcinogenesis to clinical transformation Jundan Zheng, Tianle He, Jiaxin Chen, Jixin Zhao, Shuobo Zhang, Zhenguo Yang Journal of Advanced Research.2026; 84: 1167. CrossRef
Metabolomic analysis of subgingival plaque, identification of diagnostic biomarkers and associated mechanisms in patients with HCC and periodontitis vs. periodontitis alone Jingli Zhu, Hai He, Yachen Xiao, Yichu Li, Liang Liu, Qisheng Shen, Jiaxue Yuan, Jing Wang, Tianzhu Song Clinical Oral Investigations.2026;[Epub] CrossRef
HBsAg Quantification‐Based Models for Predicting Hepatocellular Carcinoma Risk in Nucleos(t)ide Analogs‐Experienced Patients With Chronic Hepatitis B: The HBsAg‐HCC Score Yi‐Fan Guo, Xiao‐Xia Niu, Le Li, Yan Chen, Yan Liu, Chang Guo, Meng‐Qi Sun, Yi‐Zhe Zhang, Xu‐Yang Li, Chun‐Yan Wang, Jian‐Jun Wang, Lin Tan, George Lau, Dong Ji Alimentary Pharmacology & Therapeutics.2026; 64(1): 62. CrossRef
Multimorbidity patterns and their associations with healthcare services utilisation in inpatients with chronic hepatitis B infection from 2011 to 2023: a retrospective observational study Xu Wang, Jinzhao Xie, Yuankai Wu, Guanzi Chen, Huiyu Ao, Zifeng Liu, YuSheng Jie, Jing Gu BMJ Open.2026; 16(4): e106218. CrossRef
Treatment strategies for patients with hepatitis B virus infection coexisting with hepatitis C virus or metabolic dysfunction-associated steatotic liver disease Chieh Liu, Yi-Fen Shih, Chun-Jen Liu Clinical and Molecular Hepatology.2026; 32(2): 565. CrossRef
Liver Disease Diagnosis: Fuzzy c-means and Scoring Ranking Approach Gabriel A. Leite, Beatriz Flamia Azevedo, Sofia Ribeiro Ferreira, Maria F. Pacheco, Florbela P. Fernandes, Ana I. Pereira SN Computer Science.2026;[Epub] CrossRef
Association of Lipid and Inflammatory Profiles With Tumor Stage in Hepatocellular Carcinoma Nanmu Yang, Ting Wang, Xiangjun Qian, Zhongyi Li, Hao Wang, Hang Xing, Yuanlin Xu, Shuaiya Ma, Bo Meng, Xianzhou Zhang, Feng Han, Yongmei Li, Dongxiao Li, Hao Zhuang Cancer Medicine.2026;[Epub] CrossRef
Efficacy and Safety of Switching from Entecavir to Tenofovir Alafenamide in Chronic Hepatitis B: A Multicenter Randomized Trial in Korea Hyunjae Shin, Moon Haeng Hur, Yang Hyun Baek, Chun Kyon Lee, Yong Kyun Cho, June Sung Lee, Jae Yoon Jeong, Yong Jin Jung, Ja Kyung Kim, Moon Young Kim, Yeon Seok Seo, Woo Jin Chung, Moon Soo Koh, Jeong-Han Kim, Yun Bin Lee, Eun Ju Cho, Jeong-Hoon Lee, Su Gut and Liver.2026; 20(4): 636. CrossRef
Cardiometabolic Biomarkers for Disease Severity Prediction in Metabolic Dysfunction‐Associated Steatotic Liver Disease Jee‐Fu Huang, Chi‐Yi Chen, Ming‐Jong Bair, Tzu‐Chun Lin, Ming‐Lun Yeh, Pei‐Chien Tsai, Yu‐Ju Wei, Chih‐Wen Wang, Po‐Chen Liang, Ming‐Yen Hsieh, Mei‐Hsuan Lee, Chia‐Yen Dai, Chung‐Feng Huang, Ming‐Lung Yu, Wan‐Long Chuang The Kaohsiung Journal of Medical Sciences.2026;[Epub] CrossRef
Reply to correspondence on “Comparative risk of fibrosis progression with sodium-glucose cotransporter-2 vs. dipeptidyl peptidase-4 inhibitors in metabolic dysfunction-associated steatotic liver disease and type 2 diabetes mellitus with low-to-intermediat Yang-Hsiang Lin, Ching-Chih Hu, Chih-Lang Lin Clinical and Molecular Hepatology.2026; 32(3): e434. CrossRef
A machine learning model to predict liver-related outcomes after the functional cure of chronic hepatitis B Moon Haeng Hur, Terry Cheuk-Fung Yip, Seung Up Kim, Hyun Woong Lee, Han Ah Lee, Hyung-Chul Lee, Grace Lai-Hung Wong, Vincent Wai-Sun Wong, Jun Yong Park, Sang Hoon Ahn, Beom Kyung Kim, Hwi Young Kim, Yeon Seok Seo, Hyunjae Shin, Jeayeon Park, Yunmi Ko, Yo Journal of Hepatology.2025; 82(2): 235. CrossRef
Risk of de novo HCC in patients with MASLD following direct-acting antiviral-induced cure of HCV infection Chen-Hua Liu, Pin-Nan Cheng, Yu-Jen Fang, Chi-Yi Chen, Wei-Yu Kao, Chih-Lin Lin, Sheng-Shun Yang, Yu-Lueng Shih, Cheng-Yuan Peng, Yu-Ping Chang, Shang-Chin Huang, Tung-Hung Su, Tai-Chung Tseng, Chun-Jen Liu, Pei-Jer Chen, Jia-Horng Kao Journal of Hepatology.2025; 82(4): 582. CrossRef
AI model using CT-based imaging biomarkers to predict hepatocellular carcinoma in patients with chronic hepatitis B Hyunjae Shin, Moon Haeng Hur, Byeong Geun Song, Soo Young Park, Gi-Ae Kim, Gwanghyeon Choi, Joon Yeul Nam, Minseok Albert Kim, Youngsu Park, Yunmi Ko, Jeayeon Park, Han Ah Lee, Sung Won Chung, Na Ryung Choi, Min Kyung Park, Yun Bin Lee, Dong Hyun Sinn, Se Journal of Hepatology.2025; 82(6): 1080. CrossRef
Advances and challenges in molecular understanding, early detection, and targeted treatment of liver cancer Ji Shi, Xu Zhu, Jun-Bo Yang World Journal of Hepatology.2025;[Epub] CrossRef
A Global Perspective on Metabolically Driven Primary Liver Cancer: Opportunities and Challenges Joseph C. Ahn American Journal of Gastroenterology.2025; 120(10): 2240. CrossRef
Impact of high body mass index on hepatocellular carcinoma risk in chronic liver disease: A population-based prospective cohort study Moonho Kim, Baek Gyu Jun, Hwang Sik Shin, Jee-Jeon Yi, Sang Gyune Kim, Sang-Wook Yi, Sona Frankova PLOS ONE.2025; 20(1): e0316175. CrossRef
Hepatocellular carcinoma surveillance after sustained virological response in chronic hepatitis C: Editorial on “Non-invasive prediction of post-sustained virological response hepatocellular carcinoma in hepatitis C virus: A systematic review and meta-ana Ho Soo Chun, Minjong Lee Clinical and Molecular Hepatology.2025; 31(1): 261. CrossRef
Exploring How Adipose Tissue, Obesity, and Gender Influence the Immune Response to Vaccines: A Comprehensive Narrative Review Juan Bautista De Sanctis, Germán Balda Noria, Alexis Hipólito García International Journal of Molecular Sciences.2025; 26(2): 862. CrossRef
Statins exposure and adverse events in participants with chronic viral hepatitis: a meta-analysis based on cohort studies Jiale Ruan, Yingying Fang, Xingfen Zhang, Qiufeng Zhang, Jian Song npj Gut and Liver.2025;[Epub] CrossRef
Hepatitis C virus-related liver cancer among Medicaid recipients with schizophrenia, 2002–2012 Marilyn D. Thomas, Mandana Khalili, Eric Vittinghoff, Francine Cournos, Mark Olfson, Priya Dahiya, Stephen Crystal, Richard Hermida, Christina Mangurian Journal of Medicine, Surgery, and Public Health.2025; 6: 100199. CrossRef
Modulation of glucose metabolism and insulin resistance following hepatitis C virus clearance via direct-acting antivirals Sajida Jabeen, Ramsha Khan, May M. Alrashed, Sajjad Ullah, Ghulam Nabi, Malik Ihsan Ullah, Ahmed Bilal Waqar, Kotb A. Attia, Itoh Kimiko Scientific Reports.2025;[Epub] CrossRef
Overview of the prevalence and features of oncological diseases in type 2 diabetes and possible immunological mechanisms Ya. V. Dvoryanchikov, S. M. Deunezhewa, I. A. Yatskov, V. A. Beloglazov Problems of Endocrinology.2025; 71(2): 75. CrossRef
The spatio-temporal trends and determinants of liver cancer attributable to specific etiologies: a systematic analysis from the Global Burden of Disease Study 2021 Jinli Liu, Tingling Xu, Yanan Wang, Fanpu Ji, Lei Zhang Global Health Research and Policy.2025;[Epub] CrossRef
Liver and obesity: a narrative review Amedeo Lonardo, Ralf Weiskirchen Exploration of Medicine.2025;[Epub] CrossRef
The Protective Role of miR-125b in Hepatocellular Carcinoma: Unraveling Tumor-Suppressive Mechanisms Mahrokh Abouali Gale Dari, Vahid Vahedian, Bartosz Kempisty, Olanrewaju B. Morenikeji, Maryam Farzaneh, Amir Anbiyaiee Current Molecular Medicine.2025; 25(6): 663. CrossRef
The Lancet Commission on addressing the global hepatocellular carcinoma burden: comprehensive strategies from prevention to treatment Stephen Lam Chan, Hui-Chuan Sun, Yang Xu, Hongmei Zeng, Hashem B El-Serag, Jeong Min Lee, Myron E Schwartz, Richard S Finn, Jinsil Seong, Xin Wei Wang, Valérie Paradis, Ghassan K Abou-Alfa, Lorenza Rimassa, Jia-Horng Kao, Bo-Heng Zhang, Josep M Llovet, Jo The Lancet.2025; 406(10504): 731. CrossRef
Gold/Prussian Blue-Based Nanocomposites with Dual Nanozyme Activities Exert a Synergistic Effect of Starvation Therapy and Sonodynamic Therapy in the Treatment of Liver Cancer Shengnan Huang, Chengzhi Song, Tengyue Zhao, Yefei Yang, Zhiwei Yao, Shaofeng Duan, Wanyi Chen, Lixian Li, Xiaogang Hu, Chunming Li, Yurong Hu International Journal of Nanomedicine.2025; Volume 20: 10721. CrossRef
Global burden of cirrhosis and other chronic liver diseases caused by specific etiologies from 1990 to 2021 Ying Zhang, Ming Luo, Yingzi Ming BMC Gastroenterology.2025;[Epub] CrossRef
Prediction Model for Risk of Hepatocellular Carcinoma After Hepatitis C Viral Eradication Wei-Fan Hsu, Ching-Chu Lo, Kuo-Chih Tseng, Hsueh-Chou Lai, Chi-Yi Chen, Cheng-Yuan Peng Journal of Hepatocellular Carcinoma.2025; Volume 12: 2327. CrossRef
Global burden, trends, and inequalities in cancer and subtypes attributable to high BMI among older adults, 1990–2021: a secondary analysis of the global burden of disease study 2021 Yitong Huang, Di Qiu, Feng Xuan Frontiers in Nutrition.2025;[Epub] CrossRef
Global burden of hepatitis C virus infection related to high body mass index and future forecast: an analysis based on the global burden of disease study 2021 Jiayi Chen, Shiyun Wu, Panpan Zhai, Xueting Ou, Liyang Zhou, Xingfei Pan Frontiers in Public Health.2025;[Epub] CrossRef
Towards elimination of chronic viral hepatitis in French Polynesia: results from a national population-based survey Iotefa Teiti, Maite Aubry, Philippe Glaziou, Vincent Mendiboure, Anita Teissier, Tuterarii Paoaafaite, Aurélie Simon, Kiyojiken Chung, Lisa Dian, Sophie Olivier, Pascal Pineau, Arnaud Fontanet, Bertrand Condat, Yoann Madec, Stéphane Lastère, Van-Mai Cao-L The Lancet Regional Health - Western Pacific.2024; 45: 101035. CrossRef
Advances in the Pathogenesis of Metabolic Liver Disease-Related Hepatocellular Carcinoma Pinggui Chen, Yaoxuan Li, Yunyan Dai, Zhiming Wang, Yunpeng Zhou, Yi Wang, Gaopeng Li Journal of Hepatocellular Carcinoma.2024; Volume 11: 581. CrossRef
The Role of Hepatitis Viruses as Drivers of Hepatocancerogenesis Mario Capasso, Valentina Cossiga, Maria Guarino, Luisa Ranieri, Filomena Morisco Cancers.2024; 16(8): 1505. CrossRef
Current perspectives of viral hepatitis Daisuke Usuda, Yuki Kaneoka, Rikuo Ono, Masashi Kato, Yuto Sugawara, Runa Shimizu, Tomotari Inami, Eri Nakajima, Shiho Tsuge, Riki Sakurai, Kenji Kawai, Shun Matsubara, Risa Tanaka, Makoto Suzuki, Shintaro Shimozawa, Yuta Hotchi, Ippei Osugi, Risa Katou, World Journal of Gastroenterology.2024; 30(18): 2402. CrossRef
Cardiometabolic risk factors in MASLD patients with HCC: the other side of the coin Marica Meroni, Miriam Longo, Paola Dongiovanni Frontiers in Endocrinology.2024;[Epub] CrossRef
Effectiveness of the ALT/AST ratio for predicting insulin resistance in a Korean population: A large-scale, cross-sectional cohort study Seul Ki Han, Myung Jae Seo, Taesic Lee, Moon Young Kim, Anna Di Sessa PLOS ONE.2024; 19(5): e0303333. CrossRef
Appendicular Skeletal Muscle Mass to Visceral Fat Area Ratio Predicts Hepatic Morbidities Eugene Han, Yong-ho Lee, Sang Hoon Ahn, Bong-Soo Cha, Seung Up Kim, Byung-Wan Lee Gut and Liver.2024; 18(3): 509. CrossRef
Ensemble learning enhances the precision of preliminary detection of primary hepatocellular carcinoma based on serological and demographic indices Mengxia Wang, Bo Zhuang, Shian Yu, Gang Li Frontiers in Oncology.2024;[Epub] CrossRef
Air Pollution in Cardio-Oncology and Unraveling the Environmental Nexus Wenqiang Zhu, Sadeer G. Al-Kindi, Sanjay Rajagopalan, Xiaoquan Rao JACC: CardioOncology.2024; 6(3): 347. CrossRef
Metabolic effects and cardiovascular disease risks of antiviral treatments in patients with chronic hepatitis B Hyunjae Shin, Gyung Sun Lim, Jae Woong Yoon, Yunmi Ko, Youngsu Park, Jeayeon Park, Moon Haeng Hur, Min Kyung Park, Yuri Cho, Yun Bin Lee, Eun Ju Cho, Bo Hyun Kim, Jeong‐Hoon Lee, Su Jong Yu, Jung‐Hwan Yoon, Yoon Jun Kim Journal of Medical Virology.2024;[Epub] CrossRef
Metabolic dysfunction-associated steatotic liver disease and diabetes: the cross-talk between hepatologist and diabetologist Ming-Lun Yeh, Jee-Fu Huang, Chia-Yen Dai, Chung-Feng Huang, Ming-Lung Yu, Wan-Long Chuang Expert Review of Gastroenterology & Hepatology.2024; 18(8): 431. CrossRef
Association between obesity and liver cancer from 2012 to 2023: Bibliometric analysis and global trends Donghong Wang, Zhibin Ma Medicine.2024; 103(31): e39167. CrossRef
Glycaemic control is a modifiable risk factor for hepatocellular carcinoma and liver‐related mortality in patients with diabetes Xianhua Mao, Ka‐Shing Cheung, Jing‐Tong Tan, Lung‐Yi Mak, Chi‐Ho Lee, Chi‐Leung Chiang, Ho‐Ming Cheng, Rex Wan‐Hin Hui, Wai K. Leung, Man‐Fung Yuen, Wai‐Kay Seto Alimentary Pharmacology & Therapeutics.2024; 60(10): 1398. CrossRef
Impact of Diabetes Mellitus and Obesity Comorbidities on Survival Outcomes after Hepatocellular Carcinoma Resection: A Multicenter Retrospective Study Hiroji Shinkawa, Masaki Kaibori, Masaki Ueno, Satoshi Yasuda, Hisashi Ikoma, Tsukasa Aihara, Takuya Nakai, Masahiko Kinoshita, Hisashi Kosaka, Shinya Hayami, Yasuko Matsuo, Ryo Morimura, Takayoshi Nakajima, Chihoko Nobori, Takeaki Ishizawa Liver Cancer.2024; : 1. CrossRef
Liver Cancer Etiology: Old Issues and New Perspectives Jian-Guo Chen, Yong-Hui Zhang, Jian-Hua Lu, Thomas W. Kensler Current Oncology Reports.2024; 26(11): 1452. CrossRef
Deep learning assisted biomarker development in patients with chronic hepatitis B: Editorial on “Prognostic role of computed tomography analysis using deep learning algorithm in patients with chronic hepatitis B viral infection” Yong Eun Chung Clinical and Molecular Hepatology.2024; 30(4): 669. CrossRef
Clinical care guidance in patients with diabetes and metabolic dysfunction–associated steatotic liver disease: A joint consensus Jee-Fu Huang, Tien-Jyun Chang, Ming-Lun Yeh, Feng-Chih Shen, Chi-Ming Tai, Jung-Fu Chen, Yi-Hsiang Huang, Chih-Yao Hsu, Pin-Nan Cheng, Ching-Ling Lin, Chao-Hung Hung, Ching-Chu Chen, Mei-Hsuan Lee, Chun-Chuan Lee, Chih-Wen Lin, Sung-Chen Liu, Hwai-I Yang, Hepatology Communications.2024;[Epub] CrossRef
Beyond the Liver: A Comprehensive Review of Strategies to Prevent Hepatocellular Carcinoma Natchaya Polpichai, Sakditad Saowapa, Pojsakorn Danpanichkul, Shu-Yen Chan, Leandro Sierra, Johanna Blagoie, Chitchai Rattananukrom, Pimsiri Sripongpun, Apichat Kaewdech Journal of Clinical Medicine.2024; 13(22): 6770. CrossRef
A predicted epithelial-to-mesenchymal transition-associated mRNA/miRNA axis contributes to the progression of diabetic liver disease Alina-Veronica Ghionescu, Andrei Sorop, Ekaterini Linioudaki, Cristin Coman, Lorand Savu, Marton Fogarasi, Daniela Lixandru, Simona Olimpia Dima Scientific Reports.2024;[Epub] CrossRef
Evolution of characteristics of MASLD with and without diabetes: a meta-analysis of placebo arms Han Ah Lee, Hye Ah Lee, Hwi Young Kim Scientific Reports.2024;[Epub] CrossRef
Type 2 diabetes mellitus characteristics affect hepatocellular carcinoma development in chronic hepatitis B patients with cirrhosis Man-Yu Li, Ting-Ting Li, Ke-Jian Li, Cheng Zhou World Journal of Clinical Cases.2023; 11(5): 1009. CrossRef
Causes and risk profiles of mortality among individuals with nonalcoholic fatty liver disease Peter Konyn, Aijaz Ahmed, Donghee Kim Clinical and Molecular Hepatology.2023; 29(Suppl): S43. CrossRef
Surveillance of the progression and assessment of treatment endpoints for nonalcoholic steatohepatitis Yi-wen Shi, Jian-Gao Fan Clinical and Molecular Hepatology.2023; 29(Suppl): S228. CrossRef
A new model predicts hepatocellular carcinoma in patients with HBV-related decompensated liver cirrhosis and long-term antiviral therapy: a prospective study Hao-dan Mao, Shu-qin Zheng, Su-hua Yang, Ze-yu Huang, Yuan Xue, Min Zhou PeerJ.2023; 11: e15014. CrossRef
Understanding the causes of recurrent HCC after liver resection and radiofrequency ablation Carlo Bosi, Margherita Rimini, andrea Casadei-Gardini, Giorgio Ercolani Expert Review of Anticancer Therapy.2023; 23(5): 503. CrossRef
Serum resistin and the risk for hepatocellular carcinoma in diabetic patients Mona Mohamed Ibrahim Abdalla World Journal of Gastroenterology.2023; 29(27): 4271. CrossRef
On-treatment risks of cirrhosis and hepatocellular carcinoma among a large cohort of predominantly non-Asian patients with non-cirrhotic chronic hepatitis B Zeyuan Yang, Ramsey C. Cheung, Amit S. Chitnis, Wei Zhang, Robert G. Gish, Robert J. Wong JHEP Reports.2023; 5(10): 100852. CrossRef
Familial coaggregation of MASLD with hepatocellular carcinoma and adverse liver outcomes: Nationwide multigenerational cohort study Fahim Ebrahimi, Hannes Hagström, Jiangwei Sun, David Bergman, Ying Shang, Wen Yang, Bjorn Roelstraete, Jonas F. Ludvigsson Journal of Hepatology.2023; 79(6): 1374. CrossRef
Bioimpedance analysis predicts the etiology of cirrhosis in a prospective cohort study Hashem B. El-Serag, Ghida Akhdar, Aaron P. Thrift, Michelle Luster, Saira Khaderi, Abeer Alsarraj, Hao Duong, Fasiha Kanwal Hepatology Communications.2023;[Epub] CrossRef
Letter: Entecavir versus tenofovir on serum lipoprotein levels of hepatitis B virus‐related hepatocellular carcinoma after curative hepatectomy—Author's reply Eiichi Ogawa Alimentary Pharmacology & Therapeutics.2023; 58(8): 845. CrossRef
Effects of visceral obesity on cytokine and hormonal regulation in patients with gastroesophageal reflux disease Yu.M. Stepanov, L.M. Mosiychuk, O.M. Tatarchuk, O.M. Shevtsova, O.P. Petishko GASTROENTEROLOGY.2023; 57(3): 135. CrossRef
Life-long consumption of high level of fruits and vegetables reduces tumor incidence and extends median lifespan in mice Weimin Guo, Edwin F. Ortega, Dayong Wu, Lijun Li, Roderick T. Bronson, Sarah K. Boehm, Simin Nikbin Meydani Frontiers in Nutrition.2023;[Epub] CrossRef
First
Prev
